OXYNTOMODULIN PEPTIDANALOG

European patent · EP2515928 · In force

Register entry

Publication number
EP2515928
Application number
EP10801033
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 15, 2010
Published
Oct 31, 2012
Granted
Jun 18, 2014
Protection ends at the latest
Dec 14, 2030
Next annual fee due
Dec 31, 2026
IPC classes
A61K 38/17 (2006.01)
A61K 38/26 (2006.01)
C07K 14/605 (2006.01)
A61P 3/04 (2006.01)
A61P 3/10 (2006.01)
Priority
US 352576 P 08.06.2010
US 288888 P 22.12.2009
PCT application
PCT/US2010/060390 15.12.2010
PCT publication
WO2011/087672 21.07.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Dec 21, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 21.12.2023

  5. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  6. Jun 18, 2014

    Granted

    Published in Swissreg on 18.06.2014

  7. Jun 18, 2014

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 18.06.2014

Parties

Holder

Eli Lilly and Company

Lilly Corporate Center, Indianapolis, IN 46285, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

ALSINA-FERNANDEZ, Jorge

Indianapolis, IN 46285, US

KOHN, Wayne, David

Indianapolis, IN 46285, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.